Growth Metrics

Tandem Diabetes Care (TNDM) Free Cash Flow Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn 122.53%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 122.53%
Dec 31, 2025 -135.38%
Sep 30, 2025 -60.51%
Jun 30, 2025 35.24%
Mar 31, 2025 -70.59%
Dec 31, 2024 130.43%
Sep 30, 2024 502.99%
Jun 30, 2024 36.39%
Mar 31, 2024 44.40%
Dec 31, 2023 5,829.02%
Sep 30, 2023 -152.23%
Jun 30, 2023 -253.85%
Mar 31, 2023 -300.74%
Dec 31, 2022 -96.98%
Sep 30, 2022 -69.59%
Jun 30, 2022 -117.76%
Mar 31, 2022 -59.81%
Dec 31, 2021 -59.42%
Sep 30, 2021 141.69%
Jun 30, 2021 37.95%
Mar 31, 2021 201.33%
Dec 31, 2020 561.06%
Sep 30, 2020 -32.98%
Jun 30, 2020 349.40%
Mar 31, 2020 -395.25%
Dec 31, 2019 -78.70%
Sep 30, 2019 707.07%
Jun 30, 2019 171.79%
Mar 31, 2019 55.71%
Dec 31, 2018 164.81%
Sep 30, 2018 77.24%
Jun 30, 2018 64.32%
Mar 31, 2018 40.64%
Dec 31, 2017 -5.89%
Sep 30, 2017 25.91%
Jun 30, 2017 -8.14%
Mar 31, 2017 -28.41%
Dec 31, 2016 -37.00%
Sep 30, 2016 -19.92%
Jun 30, 2016 13.06%
Mar 31, 2016 -2.27%
Dec 31, 2015 16.57%
Sep 30, 2015 -16.29%
Jun 30, 2015 -7.07%
Mar 31, 2015 13.77%
Dec 31, 2014 0.16%
Sep 30, 2014 -20.56%
Jun 30, 2014 -17.15%
Mar 31, 2014 -91.32%